ARCHIVES

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

This article is from The Cancer Letter archive.

Vol. 25 No. 6 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

Virus Studies Approved By DCE Board for $2.5 Mil. In First Year

November 3, 1989

December issue of Business & Regulatory Report included (an additional 8 pages of industry news).

December 10, 2004

Radiation Oncologist Objects To ACR Comments Results

November 27, 1981

NIH Panel Urges Wider Treatment of Hepatitis C

June 14, 2002

In Brief :Three Named to Leadership Posts At St. Jude; Mitchell Weiss Appointed Chair of Hematology

June 11, 2014

No Cancer Letter For Two Weeks

August 10, 1990